Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for ARS Pharmaceuticals, Inc.
Goto 0, 1, 2, 3, Next
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2023-09-21
Purchase		2023-09-25
4:30 pm		ARS Pharmaceuticals Inc.SPRYRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director		2,700,000$3.0309$8,183,5269,459,678
(Indirect)		View
2023-09-01
Sale		2023-09-05
8:04 pm		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		100,000$7.7052$770,520265,581
(Direct)		View
2023-08-29
Purchase		2023-08-31
5:26 pm		ARS Pharmaceuticals Inc.SPRYRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director		3,750,000$6.2$23,250,0006,759,678
(Indirect)		View
2023-08-29
Purchase		2023-08-31
5:26 pm		ARS Pharmaceuticals Inc.SPRYORBIMED ADVISORS LLC
OrbiMed Capital GP VI LLC
ORBIMED CAPITAL LLC
Director		500,000$6.2$3,100,0009,240,887
(Indirect)		View
2023-08-29
Purchase		2023-08-31
5:18 pm		ARS Pharmaceuticals Inc.SPRYThompson Peter A.
Director		500,000$6.2$3,100,0009,240,887
(Indirect)		View
2023-08-03
Sale		2023-08-07
5:05 pm		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		45,004$7.0325$316,489235,237
(Direct)		View
2023-08-01
Sale		2023-08-03
6:03 pm		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		54,996$7.1249$391,841342,629
(Direct)		View
2023-07-07
Sale		2023-07-07
8:16 pm		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		8,858$6.364$56,372313,343
(Direct)		View
2023-07-03
Sale		2023-07-06
8:55 pm		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		91,142$6.4784$590,453644,043
(Direct)		View
2023-06-01
Sale		2023-06-02
7:48 pm		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		100,000$6.8404$684,041643,281
(Direct)		View
2022-11-09
Sale		2023-05-10
4:53 pm		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		143,896$5.4246$780,579859,240
(Direct)		View
2022-11-29
Purchase		2022-12-01
4:31 pm		ARS Pharmaceuticals Inc.SPRYScott Kathleen D.
Chief Financial Officer		8,250$6.2432$51,5068,250
(Indirect)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2023-09-01
Exercise		2023-09-05
8:04 pm		N/A
2030-04-28		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		100,000$0265,581
(Direct)		View
2023-09-01
Exercise		2023-09-05
8:04 pm		N/A
N/A		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		100,000$1.27265,581
(Direct)		View
2023-08-03
Exercise		2023-08-07
5:05 pm		N/A
2030-04-28		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		44,914$0235,237
(Direct)		View
2023-08-03
Exercise		2023-08-07
5:05 pm		N/A
N/A		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		45,004$1.27235,237
(Direct)		View
2023-08-01
Exercise		2023-08-03
6:03 pm		N/A
2030-04-28		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		54,996$0342,629
(Direct)		View
2023-08-01
Exercise		2023-08-03
6:03 pm		N/A
N/A		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		54,996$1.27342,629
(Direct)		View
2023-07-07
Exercise		2023-07-07
8:16 pm		N/A
2030-04-28		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		8,858$0313,343
(Direct)		View
2023-07-07
Exercise		2023-07-07
8:16 pm		N/A
N/A		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		8,858$1.27313,343
(Direct)		View
2023-07-03
Exercise		2023-07-06
8:55 pm		N/A
2030-04-28		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		91,142$0644,043
(Direct)		View
2023-07-03
Exercise		2023-07-06
8:55 pm		N/A
N/A		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		91,142$1.27644,043
(Direct)		View
2023-06-27
Option Award		2023-06-28
9:03 pm		N/A
2033-06-26		ARS Pharmaceuticals Inc.SPRYDadoo Rajeev
Director		40,000$040,000
(Direct)		View
2023-06-27
Option Award		2023-06-28
9:00 pm		N/A
2033-06-26		ARS Pharmaceuticals Inc.SPRYRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director		40,000$040,000
(Indirect)		View
2023-06-27
Option Award		2023-06-28
9:00 pm		N/A
2033-06-26		ARS Pharmaceuticals Inc.SPRYKelly Michael
Director		40,000$040,000
(Direct)		View
2023-06-27
Option Award		2023-06-28
9:00 pm		N/A
2033-06-26		ARS Pharmaceuticals Inc.SPRYShah Pratik
Director
10% Owner		40,000$040,000
(Direct)		View
2023-06-27
Option Award		2023-06-28
9:00 pm		N/A
2033-06-26		ARS Pharmaceuticals Inc.SPRYThompson Peter A.
Director
10% Owner		40,000$040,000
(Direct)		View
2023-06-27
Option Award		2023-06-28
9:00 pm		N/A
2033-06-26		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		40,000$040,000
(Direct)		View
2023-06-27
Option Award		2023-06-28
9:00 pm		N/A
2033-06-26		ARS Pharmaceuticals Inc.SPRYSAUNDERS BRENT L
Director		40,000$040,000
(Direct)		View
2023-06-27
Option Award		2023-06-28
9:00 pm		N/A
2033-06-26		ARS Pharmaceuticals Inc.SPRYSCHNEIDER PHILLIP M
Director		40,000$040,000
(Direct)		View
2023-06-27
Option Award		2023-06-28
9:00 pm		N/A
2033-06-26		ARS Pharmaceuticals Inc.SPRYIslam Saqib
Director		40,000$040,000
(Direct)		View
2023-06-01
Exercise		2023-06-02
7:48 pm		N/A
2030-04-28		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		100,000$0643,281
(Direct)		View
2023-06-01
Exercise		2023-06-02
7:48 pm		N/A
N/A		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		100,000$1.27643,281
(Direct)		View
2023-05-08
Exercise		2023-05-10
4:53 pm		N/A
2030-04-28		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		100,000$0859,240
(Direct)		View
2023-05-08
Exercise		2023-05-10
4:53 pm		N/A
N/A		ARS Pharmaceuticals Inc.SPRYShawver Laura
Director		100,000$1.27859,240
(Direct)		View
2023-01-03
Option Award		2023-01-05
5:00 pm		N/A
2033-01-02		ARS Pharmaceuticals Inc.SPRYScott Kathleen D.
Chief Financial Officer		50,000$050,000
(Direct)		View
2023-01-03
Option Award		2023-01-05
5:00 pm		N/A
2033-01-02		ARS Pharmaceuticals Inc.SPRYFitzpatrick Alexander A
Chief Legal Officer		700,000$0700,000
(Direct)		View
2023-01-03
Option Award		2023-01-05
5:00 pm		N/A
2033-01-02		ARS Pharmaceuticals Inc.SPRYChakma Justin
Chief Business Officer		165,000$0165,000
(Direct)		View
2023-01-03
Option Award		2023-01-05
5:00 pm		N/A
2033-01-02		ARS Pharmaceuticals Inc.SPRYDorsey Brian
Chief Operating Officer		145,000$0145,000
(Direct)		View
2023-01-03
Option Award		2023-01-05
5:00 pm		N/A
2033-01-02		ARS Pharmaceuticals Inc.SPRYKaras Eric
Chief Commercial Officer		50,000$050,000
(Direct)		View
2023-01-03
Option Award		2023-01-05
5:00 pm		N/A
2033-01-02		ARS Pharmaceuticals Inc.SPRYTanimoto Sarina
Chief Medical Officer
10% Owner		1,450,000$01,450,000
(Direct)		View
2023-01-03
Option Award		2023-01-05
5:00 pm		N/A
2033-01-02		ARS Pharmaceuticals Inc.SPRYLowenthal Richard E
President and CEO
10% Owner		1,450,000$01,450,000
(Direct)		View

Ownership		2022-12-09
5:06 pm		2018-11-29
2028-11-28		ARS Pharmaceuticals Inc.SPRYDorsey Brian
Chief Operating Officer		0$0603,359
(Direct)		View

Ownership		2022-11-10
7:48 pm		N/A
N/A		ARS Pharmaceuticals Inc.SPRYFlynn James E
Deerfield Mgmt III L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Private Design Fund III L.P.
Deerfield Mgmt IV L.P.
Deerfield Private Design Fund IV L.P.
Director by deputization
Director
10% Owner		0$011,077,928
(Indirect)		View
2022-11-08
Option Award		2022-11-10
6:00 pm		N/A
2029-07-05		ARS Pharmaceuticals Inc.SPRYChakma Justin
Chief Business Officer		603,753$0840,133
(Direct)		View
2022-11-08
Option Award		2022-11-10
6:00 pm		N/A
2031-11-30		ARS Pharmaceuticals Inc.SPRYShah Pratik
Pratik Shah Living Trust dated June 15 2011
Director
10% Owner		10,510,774$010,510,774
(Direct)		View
2022-11-08
Option Award		2022-11-10
6:00 pm		N/A
2032-05-24		ARS Pharmaceuticals Inc.SPRYKaras Eric
Chief Commercial Officer		614,588$0614,588
(Direct)		View
2022-11-08
Option Award		2022-11-10
6:00 pm		N/A
2029-07-05		ARS Pharmaceuticals Inc.SPRYSCHNEIDER PHILLIP M
Director		230,470$0230,470
(Direct)		View
2022-11-08
Option Award		2022-11-10
6:00 pm		N/A
N/A		ARS Pharmaceuticals Inc.SPRYRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director		3,009,678$0902,904
(Indirect)		View
2022-11-08
Option Award		2022-11-10
6:00 pm		N/A
2029-12-16		ARS Pharmaceuticals Inc.SPRYTanimoto Sarina
Chief Medical Officer
10% Owner		6,737,930$09,291,934
(Direct)		View
2022-11-08
Option Award		2022-11-10
6:00 pm		N/A
2029-12-16		ARS Pharmaceuticals Inc.SPRYLowenthal Richard E
President and CEO
10% Owner		11,914,752$07,587,898
(Direct)		View
2022-11-08
Option Award		2022-11-10
6:00 pm		N/A
2031-06-15		ARS Pharmaceuticals Inc.SPRYSAUNDERS BRENT L
Director		744,597$0744,597
(Direct)		View
2022-11-08
Option Award		2022-11-10
6:00 pm		N/A
2029-07-04		ARS Pharmaceuticals Inc.SPRYKelly Michael
Director		271,837$0271,837
(Direct)		View
Goto 0, 1, 2, 3, Next